Livzon Pharmaceutical Group Inc. (SHE:000513)
China · Delayed Price · Currency is CNY 26.41
-0.35 (-1.31%)
Aug 31, 2026, 3:04 PM CST
SHE:000513 Market Cap
SHE:000513 has a market cap or net worth of 20.75 billion as of August 31, 2026. Its market cap has decreased by -38.22% in one year.
Market Cap
20.75B
Enterprise Value
17.14B
Revenue
10.75B
Ranking
n/a
PE Ratio
14.02
Stock Price
26.41
ChartMarket Cap Chart
Since July 14, 1997, SHE:000513's market cap has increased from 392.67M to 20.75B, an increase of 5,185.46%. That is a compound annual growth rate of 14.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 20.75B | -25.74% |
| Dec 31, 2025 | 27.95B | -8.97% |
| Dec 31, 2024 | 30.70B | 8.53% |
| Dec 29, 2023 | 28.29B | 3.04% |
| Dec 30, 2022 | 27.46B | -15.01% |
| Dec 31, 2021 | 32.31B | -2.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Walvax Biotechnology | 22.84B |
| Harbin Pharmaceutical Group | 22.67B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.39B |
| Tasly Pharmaceutical Group | 22.24B |
| Guangdong Zhongsheng Pharmaceutical | 21.97B |
| Jilin Aodong Pharmaceutical Group | 21.83B |
| Betta Pharmaceuticals | 21.27B |
| Hybio Pharmaceutical | 20.71B |